Bone Biologics (BBLGW) Restructuring Costs (2013)
Bone Biologics' (BBLGW) quarterly Restructuring Costs came in at $30.0 in Q4 2013, little changed quarter-over-quarter from $30.0 in Q3 2013.
Powered by 
Analysis
Bone Biologics (BBLGW) Restructuring Costs (2013) Analysis & Trends
Bone Biologics (BBLGW) has reported Restructuring Costs for 1 consecutive years, with $30.0 the latest figure, recorded in Q4 2013.
- On a quarterly basis, Restructuring Costs changed N/A year-over-year to $30.0 in Q4 2013; TTM through Oct 2013 was $120.0, a N/A change from a year earlier, with the FY2013 full-year figure at $120.0, changed N/A from the prior year.
- Restructuring Costs was $30.0 for Q4 2013 at Bone Biologics, roughly flat from $30.0 in the prior quarter.
- Over five years, Restructuring Costs peaked at $30.0 in Q1 2013 and troughed at $30.0 in Q1 2013.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn |
| 10 | Bone Biologics | 9.52 Mn | 9.52 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Oct 31, 2013 | 30.00 |
| Jul 31, 2013 | 30.00 |
| Apr 30, 2013 | 30.00 |
| Jan 31, 2013 | 30.00 |